222 related articles for article (PubMed ID: 33182805)
21. miR-589-5p inhibits MAP3K8 and suppresses CD90
Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
[TBL] [Abstract][Full Text] [Related]
23. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
Yang C; Cai WC; Dong ZT; Guo JW; Zhao YJ; Sui CJ; Yang JM
Gene; 2019 Mar; 687():73-81. PubMed ID: 30391438
[TBL] [Abstract][Full Text] [Related]
24. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
[TBL] [Abstract][Full Text] [Related]
25. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
[TBL] [Abstract][Full Text] [Related]
26. CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance.
Xu M; Fang S; Song J; Chen M; Zhang Q; Weng Q; Fan X; Chen W; Wu X; Wu F; Tu J; Zhao Z; Ji J
Cell Death Dis; 2018 Sep; 9(10):957. PubMed ID: 30237545
[TBL] [Abstract][Full Text] [Related]
27. Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma.
Ge JC; Wang YX; Chen ZB; Chen DF
Cell Signal; 2020 Feb; 66():109465. PubMed ID: 31698037
[TBL] [Abstract][Full Text] [Related]
28. Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.
Long J; Jiang C; Liu B; Dai Q; Hua R; Chen C; Zhang B; Li H
Cancer Lett; 2018 Jun; 423():113-126. PubMed ID: 29196128
[TBL] [Abstract][Full Text] [Related]
29. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
[TBL] [Abstract][Full Text] [Related]
30. SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.
Murakami S; Ninomiya W; Sakamoto E; Shibata T; Akiyama H; Tashiro F
Stem Cells; 2015 Sep; 33(9):2652-63. PubMed ID: 26013162
[TBL] [Abstract][Full Text] [Related]
31. CD133
Liu K; Hao M; Ouyang Y; Zheng J; Chen D
Sci Rep; 2017 Jan; 7():41499. PubMed ID: 28134312
[TBL] [Abstract][Full Text] [Related]
32. Tspan15 Is a New Stemness-Related Marker in Hepatocellular Carcinoma.
Sidahmed-Adrar N; Ottavi JF; Benzoubir N; Ait Saadi T; Bou Saleh M; Mauduit P; Guettier C; Desterke C; Le Naour F
Proteomics; 2019 Nov; 19(21-22):e1900025. PubMed ID: 31390680
[TBL] [Abstract][Full Text] [Related]
33. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
34. DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
Borghesan M; Fusilli C; Rappa F; Panebianco C; Rizzo G; Oben JA; Mazzoccoli G; Faulkes C; Pata I; Agodi A; Rezaee F; Minogue S; Warren A; Peterson A; Sedivy JM; Douet J; Buschbeck M; Cappello F; Mazza T; Pazienza V; Vinciguerra M
Cancer Res; 2016 Feb; 76(3):594-606. PubMed ID: 26772755
[TBL] [Abstract][Full Text] [Related]
35. Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer.
Ho DW; Tsui YM; Sze KM; Chan LK; Cheung TT; Lee E; Sham PC; Tsui SK; Lee TK; Ng IO
Cancer Lett; 2019 Sep; 459():176-185. PubMed ID: 31195060
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA LINC00324 exerts protumorigenic effects on liver cancer stem cells by upregulating fas ligand via PU box binding protein.
Gao J; Dai C; Yu X; Yin XB; Zhou F
FASEB J; 2020 Apr; 34(4):5800-5817. PubMed ID: 32128906
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Takahashi Y; Ueda M; Sakimura S; Uchi R; Kurashige J; Takano Y; Nanbara S; Komatsu H; Saito T; Shinden Y; Iguchi T; Eguchi H; Atsumi K; Sakamoto K; Doi T; Hirakawa M; Honda H; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1402-9. PubMed ID: 25404478
[TBL] [Abstract][Full Text] [Related]
38. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
[TBL] [Abstract][Full Text] [Related]
39. DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.
Xu X; Liu RF; Zhang X; Huang LY; Chen F; Fei QL; Han ZG
Mol Cancer Ther; 2012 Mar; 11(3):629-38. PubMed ID: 22238367
[TBL] [Abstract][Full Text] [Related]
40. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
